Evidence map›Paper›PMID 41542585›Full record

ArticlebioRxiv : the preprint server for biology2026

A teichoic acid-like wall modification associated with immune suppression is socially regulated in

Caleb M Anderson, Reid V Wilkening, Samy Boulos, Timothy G Keys, Marc-Olivier Ebert, Léa V Zinsli, Janes Krusche, Martin J Loessner, Sam F Feldstein, Jennifer C Chang and 4 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Caleb M AndersonDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.ORCID 0000-0003-3395-7805
Reid V WilkeningSection of Pediatric Critical Care Medicine, Department of Pediatrics, University of Colorado, Aurora CO.
Samy BoulosInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland.
Timothy G KeysInstitute for Microbiology, Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland.
Marc-Olivier EbertDepartment of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland.
Léa V ZinsliInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland.
Janes KruscheInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, 72076 Tübingen, Germany; Cluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections", University of Tübingen, 72076 Tübingen, Germany.ORCID 0009-0004-1900-8480
Martin J LoessnerInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland.ORCID 0000-0002-8162-2631
Sam F FeldsteinDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.ORCID 0000-0002-5367-1313
Jennifer C ChangDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.ORCID 0000-0002-6175-1284
Andreas PeschelInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, 72076 Tübingen, Germany; Cluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections", University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-3209-8626
Alexander R HorswillInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, 72076 Tübingen, Germany; Cluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections", University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-5568-0096
Yang ShenInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland.ORCID 0000-0003-4278-1477
Michael J FederleDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.ORCID 0000-0002-4554-543X

Funding

Research Training in Rheumatology INCLUDE Down Syndrome SupplementT32AR007534 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Kristine A. Kuhn · 1986 to 2026
$6.1M
Mechanistic Dissection of Pheromone-Dependent Regulation of Group A StreptococcalR01AI091779 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FEDERLE, MICHAEL J · 2011 to 2021
$3.9M
Quorum sensing, diversity and skin inflammationR01AI153185 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GALLO, RICHARD L, HORSWILL, ALEXANDER R · 2020 to 2024
$3.2M
Mechanisms of staphylococcal skin colonizationR01AI162964 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL D FEY, ANDREW B HERR · 2022 to 2026
$2.4M
Macrophage Immunosuppression by Quorum-Induced Streptococcus pyogenesR01AI162679 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FEDERLE, MICHAEL J · 2022 to 2025
$2.4M
Mechanisms of staphylococcal skin colonizationR56AI162964 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FEY, PAUL D, HERR, ANDREW B · 2021 to 2021
$651k
NIAID NIH HHS R01 AI091779NIAID NIH HHS R01 AI153185NIAID NIH HHS R01 AI162679NIAID NIH HHS R01 AI162964NIAID NIH HHS R56 AI162964NIAMS NIH HHS T32 AR007534
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glycosylationGroup A Streptococcusimmunomodulationquorum sensing

Identifiers

PMID41542585
PMCPMC12803152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.